Stronger Effect of Azilsartan on Reduction of Proteinuria Compared to Candesartan in Patients with CKD: A Randomized Crossover Trial

• मुख्य लेखकों: Takaichi Suehiro (लेखक), Kazuhiko Tsuruya (लेखक), Hisako Yoshida (लेखक), Hiroaki Tsujikawa (लेखक), Shunsuke Yamada (लेखक), Shigeru Tanaka (लेखक), Akihiro Tsuchimoto (लेखक), Masahiro Eriguchi (लेखक), Kiichiro Fujisaki (लेखक), Kumiko Torisu (लेखक), Toshiaki Nakano (लेखक), Takanari Kitazono (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Karger Publishers, 2021-03-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Introduction: Angiotensin receptor blockers (ARBs) are preferably used in hypertensive patients with CKD. Azilsartan is a strong antihypertensive ARB, but its antiproteinuric effects are not well understood. We compared the antiproteinuric effect of azilsartan and candesartan in CKD patients in an o...